Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10549409rdf:typepubmed:Citationlld:pubmed
pubmed-article:10549409lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10549409lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10549409lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:10549409lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:10549409lifeskim:mentionsumls-concept:C0521390lld:lifeskim
pubmed-article:10549409lifeskim:mentionsumls-concept:C0022009lld:lifeskim
pubmed-article:10549409lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:10549409lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:10549409pubmed:issue10lld:pubmed
pubmed-article:10549409pubmed:dateCreated1999-12-16lld:pubmed
pubmed-article:10549409pubmed:abstractText1. We investigated the ion currents responsible for repolarization of guinea-pig isolated myocytes (ICa) and rat hippocampal CA1 neurons (IA and IK) by means of the whole-cell holding technique. 2. The rat hypertrophied heart, induced by levothyroxin, caused exaggerated cardiac arrhythmias after coronary ischaemia-reperfusion. 3. We found an enhanced ICa in guinea-pig isolated myocytes and decreased IA and IK in rat hippocampal CA1 neurons following levothyroxin treatment. Blockade of the outward K+ current and an increment in inward Ca2+ current by chronic levothyroxin treatment contributed to the delayed repolarization and aggravated cardiac arrhythmias. 4. Animals treated with chronic levothyroxin may serve as pathological models for the investigation of the pattern of ion channel disorders with regard to impaired repolarization and aggravated cardiac arrhythmias.lld:pubmed
pubmed-article:10549409pubmed:languageenglld:pubmed
pubmed-article:10549409pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10549409pubmed:citationSubsetIMlld:pubmed
pubmed-article:10549409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10549409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10549409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10549409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10549409pubmed:statusMEDLINElld:pubmed
pubmed-article:10549409pubmed:monthOctlld:pubmed
pubmed-article:10549409pubmed:issn0305-1870lld:pubmed
pubmed-article:10549409pubmed:authorpubmed-author:WuC HCHlld:pubmed
pubmed-article:10549409pubmed:authorpubmed-author:AxEElld:pubmed
pubmed-article:10549409pubmed:authorpubmed-author:YangD MDMlld:pubmed
pubmed-article:10549409pubmed:authorpubmed-author:ZhangG QGQlld:pubmed
pubmed-article:10549409pubmed:authorpubmed-author:ZhouP APAlld:pubmed
pubmed-article:10549409pubmed:authorpubmed-author:HoH PHPlld:pubmed
pubmed-article:10549409pubmed:authorpubmed-author:HanX NXNlld:pubmed
pubmed-article:10549409pubmed:issnTypePrintlld:pubmed
pubmed-article:10549409pubmed:volume26lld:pubmed
pubmed-article:10549409pubmed:ownerNLMlld:pubmed
pubmed-article:10549409pubmed:authorsCompleteYlld:pubmed
pubmed-article:10549409pubmed:pagination819-21lld:pubmed
pubmed-article:10549409pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:meshHeadingpubmed-meshheading:10549409...lld:pubmed
pubmed-article:10549409pubmed:year1999lld:pubmed
pubmed-article:10549409pubmed:articleTitleChronic levothyroxin treatment is associated with ion channel abnormalities in cardiac and neuronal cells.lld:pubmed
pubmed-article:10549409pubmed:affiliationResearch Division of Pharmacology, China Pharmaceutical University, Nanjing, China. njpdaidz@jlonline.comlld:pubmed
pubmed-article:10549409pubmed:publicationTypeJournal Articlelld:pubmed